Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 9.49% |
| Q3 2025 | -14.03% |
| Q2 2025 | -9.94% |
| Q1 2025 | -2.38% |
| Q4 2024 | -5.94% |
| Q3 2024 | 22.48% |
| Q2 2024 | -15.77% |
| Q1 2024 | -7.81% |
| Q4 2023 | 5.91% |
| Q3 2023 | 7.04% |
| Q2 2023 | 1.90% |
| Q1 2023 | -11.52% |
| Q4 2022 | 22.31% |
| Q3 2022 | -6.26% |
| Q2 2022 | -1.39% |
| Q1 2022 | 6.66% |
| Q4 2021 | 18.08% |
| Q3 2021 | 8.76% |
| Q2 2021 | 11.17% |
| Q1 2021 | 45.60% |
| Q4 2020 | 21.53% |
| Q3 2020 | -2.35% |
| Q2 2020 | -39.36% |
| Q1 2020 | 50.50% |
| Q4 2019 | -17.39% |
| Q3 2019 | 5.15% |
| Q2 2019 | -3.46% |
| Q1 2019 | -1.69% |
| Q4 2018 | 48.87% |
| Q3 2018 | -9.62% |
| Q2 2018 | 0.06% |
| Q1 2018 | 3.73% |
| Q4 2017 | 3.19% |
| Q3 2017 | -10.02% |
| Q2 2017 | 1.57% |
| Q1 2017 | 17.49% |
| Q4 2016 | 9.24% |
| Q3 2016 | 6.27% |
| Q2 2016 | -4.41% |
| Q1 2016 | -8.36% |